Patent Baristas

Among the most frequently asked questions I get from start-up companies is: How much should I pay for licensing in a technology? Answer: As little as possible. Kidding aside, this is really a very complicated question that cannot be answered without a lot of homework. While most companies seem to use a valuation method I […]

Red Herring this week ran an interesting article about a company called PeopleConnect. Basically, PeopleConnect helps high-tech startups hire pricey executives without actually having to pay them any cash. Angel Employees, like Angel Investors, invest their labor in exchange for an equity stake in the company. The companies, meanwhile, get top notch management while keeping […]

Forbes recently ran an article showing that companies that generate revenue from products protected by copyrights or patents are vital to the U.S. economy. In a report, NBC Universal Chief Executive Bob Wright released the results of the study he commissioned, which shows that digital piracy, if not reined in, could cause the U.S. economy […]

Andrew Raff at the IPTAblog reports on news, analysis and commentary about issues in IP, technology and privacy law and related topics. This week, he brings you an excellent round-up of law blogs for Blawg Review #31. In Act III: Internet and IP, Raff describes this past weeks highlights in IP including a post by […]

No, this post is not about the NFL or NBA, but if I’d titled it the Probabilistics Of Reverse Payment Hatch-Waxman Settlements, then you would have stopped before reading this far. Suits for antitrust relief based on settlements, in which pharmaceutical patent owners settled and paid makers of generics to delay entering the market, recently […]

Panexa. Ask Your Doctor For A Reason To Take It Panexa (Acidachrome Promanganate). No matter what you do or where you go, you’re always going to be yourself. And Panexa knows this. Your lifestyle is one of the biggest factors in choosing how to live. Why trust it to anything less? Panexa is proven to […]

The U.S. Supreme Court has agreed to review a case relating to subject matter issues under 35 U.S.C. §101 for a patent that allegedly claims “laws of nature, natural phenomena, and abstract ideas” in Laboratory Corp. of America v. Metabolite Laboratories, U.S., No. 04-607, 10/31/05. Review was granted only with respect to question 3 in […]

The recent decision, about a backbone stabilizing device, in Cross Medical Prods. v. Medtronic Sofamor Danek, 424 F.3d 1293 (Fed. Cir. 2005), may be a reminder why so many commentators have weighed in on the need to reform the Patent Act, or to reign in judicially-created rules. The panel decision in Cross Medical works out […]